Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshington Innov Regulatory News (ASHI)

Share Price Information for Ashington Innov (ASHI)

Share Price is delayed by 15 minutes
Get Live Data
0.75    0.00 (0.00%)
Bid:
0.60
Ask:
0.90
Spread: 0.30 (50.00%)
Market Cap: £544.48k
ASHI Live PriceLast checked at - London Stock Exchange

Intraday Ashington Innov Share Chart

Results of General Meeting

22 Jul 2025 13:40

RNS Number : 0978S
Ashington Innovation PLC
22 July 2025
 

22 July 2025

 

Ashington Innovation plc

 

("Ashington" or "the Company")

 

Results of General Meeting

 

Ashington Innovation plc (LSE: ASHI; FSE: 6FW), a special purpose acquisition company ("SPAC"), is pleased to announce that the special resolution to amend its articles of association to comply with UKLR 13.2.1R was duly passed.

 

Proxy votes received were:

 

FOR

AGAINST

WITHHELD

47,564,566

0

0

 

 

A copy of the resolution passed at this meeting has been loaded into the National Storage Mechanism (https://data.fca.org.uk/#/nsm/nationalstoragemechanism).

 

For further information please contact:

 

Ashington Innovation plc

info@ashingtoninnovation.com

Jason Smart (Non-executive Director)

+44 7808 904 254

 

 

About Ashington Innovation plc

 

Ashington Innovation plc is a special purpose acquisition company (SPAC), formed with the intention of acquiring businesses operating in the technology sector, in particular the financial services technology and deep technology sectors.

 

The Company believes that in the increasingly fast-changing global environment there will be an abundance of opportunities to acquire existing businesses in the technology sector, and in particular businesses that possess and utilise proprietary technologies and own applicable intellectual property.

 

The Company is not limited to any specific geographic region in identifying its target companies. www.ashingtoninnovation.com .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMBDGDRCDDDGUD
Date   Source Headline
18th Jun 202612:30 pmRNSResults of Annual General Meeting
26th May 20264:45 pmRNSNotice of Annual General Meeting
30th Apr 20267:00 amRNSAnnual results
5th Dec 20255:20 pmRNSNotice of General Meeting
30th Sep 20257:00 amRNSInterim results
22nd Jul 20251:40 pmRNSResults of General Meeting
3rd Jul 20259:55 amRNSNotice of GM
9th Jun 20254:20 pmRNSResults of Annual General Meeting
15th May 20254:00 pmRNSNotice of Annual General Meeting
30th Apr 20257:00 amRNSAnnual Report
4th Oct 20246:15 pmRNSTR-1: Standard notification of major holdings
4th Oct 20246:15 pmRNSTR-1: Standard notification of major holdings
30th Sep 20247:00 amRNSInterim results
15th Aug 20244:20 pmRNSTR-1: Standard notification of major holdings
31st Jul 20247:00 amRNSRetrospective applications and corrections
25th Jul 20247:00 amRNSFundraise
17th Jun 202412:50 pmRNSResults of Annual General Meeting
24th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20246:19 pmRNSAnnual results
25th Jan 20247:30 amRNSRestoration - Ashington Innovation PLC
24th Jan 20247:00 amRNSTermination of Proposed Reverse Takeover
12th Jan 202412:30 pmRNSResults of Annual General Meeting
20th Dec 20232:00 pmRNSPosting of Annual Report and Notice of AGM
20th Dec 20231:15 pmRNSIssue of Equity
20th Dec 20237:00 amRNSAppointment of New Auditors
8th Nov 20233:30 pmRNSBoard changes
16th Oct 20237:00 amRNSAppointment of Non-Executive Director
5th Sep 20237:00 amRNSUpdate on Cell Therapy and Calon Discussions
24th Aug 20237:00 amRNSHeads of Terms Signed for the Acquisition of Calon
21st Aug 20237:00 amRNSDual Listing on the Frankfurt Stock Exchange
17th Aug 20238:10 amRNSHeads of Terms Signed
17th Aug 20237:30 amRNSSuspension - Ashington Innovation PLC
16th Aug 20237:00 amRNSBoard Change
9th Aug 202312:26 pmRNSChange of Accounting Reference Date
6th Jun 20238:01 amRNSAshington - Admission to trading on the LSE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.